Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of randall’s plaque

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 10, 2014, Pages 1757-1763

  Wang, Xiangling ^a   Krambeck, Amy E ^a   Williams, James C ^c   Tang, Xiaojing ^a   Rule, Andrew D ^a   Zhao, Fang ^a   Bergstralh, Eric ^a   Haskic, Zejfa ^a   Edeh, Samuel ^a   Holmes, David R ^b   Herrera Hernandez, Loren P ^a   Lieske, John C ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; PROTEINASE INHIBITOR; WHEWELLITE; BIOLOGICAL MARKER; CALCIUM PHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FLUOROSCOPY; GARDNERELLA VAGINALIS; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; KIDNEY BIOPSY; KIDNEY CALCIFICATION; KIDNEY PAPILLA; MALE; MICRO-COMPUTED TOMOGRAPHY; NEPHROLITHIASIS; NEPHROSCOPE; PROTEIN URINE LEVEL; PSEUDOMONAS; RANDALL PLAQUE; RISK FACTOR; STRUCTURED QUESTIONNAIRE; URINALYSIS; UROLITHIASIS; AGED; BIOPSY; CHEMISTRY; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; CRYSTALLIZATION; ENDOSCOPY; KIDNEY; KIDNEY CALCULI; MIDDLE AGED; OBESITY; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RADIOGRAPHY; URINARY EXCRETION; URINARY TRACT INFECTION; URINE;

AGED; BIOMARKERS; BIOPSY; CALCIUM OXALATE; CALCIUM PHOSPHATES; CROSS-SECTIONAL STUDIES; CRYSTALLIZATION; ENDOSCOPY; FEMALE; HUMANS; KIDNEY; KIDNEY CALCULI; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL ELIMINATION; RISK FACTORS; URINALYSIS; URINARY TRACT INFECTIONS; X-RAY MICROTOMOGRAPHY;

EID: 84923812622     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01490214     Document Type: Article

References (24)

1. Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project: Prevalence of kidney stones in the United States. Eur Urol 62: 160–165, 2012
2. Miller NL, Gillen DL, Williams JC Jr, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE: A formal test of the hypothesis that idiopathic calciumoxalate stones grow on Randall’s plaque. BJU Int 103: 966–971, 2009
3. Evan AP, Unwin RJ, Williams JC Jr: Renal stone disease: A commentary on the nature and significance of Randall’s plaque. Nephron, Physiol 119: 49–53, 2011
4. Miller NL: The origin and significance of Randall’s plaque in nephrolithiasis. J Urol 186: 783–784, 2011
5. Coe FL, Evan AP, Lingeman JE, Worcester EM: Plaque and deposits in nine human stone diseases. Urol Res 38: 239–247, 2010
6. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M: Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607–616, 2003
7. Matlaga BR, Williams JC Jr, Kim SC, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE: Endoscopic evidence of calculus attachment to Randall’s plaque. J Urol 175: 1720–1724, 2006
8. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL: Urine calcium and volume predict coverage of renal papilla by Randall’s plaque. Kidney Int 64: 2150–2154, 2003
9. Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE: Stone formation is proportional to papillary surface coverage by Randall’s plaque. J Urol 173: 117–119, discussion 119, 2005
10. Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL: Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res 38: 439–452, 2010
11. Linnes MP, Krambeck AE, Cornell L, Williams JC Jr, Korinek M, Bergstralh EJ, Li X, Rule AD, McCollough CM, Vrtiska TJ, Lieske JC: Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. Kidney Int 84: 818–825, 2013
12. Evan AP, Lingeman JE, Coe FL, Worcester EM: Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28: 111–119, 2008
13. Knight J, Jiang J, Wood KD, Holmes RP, AssimosDG: Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers. Urology 78: e9-e13, 2011
14. Zarse CA, Hameed TA, Jackson ME, Pishchalnikov YA, Lingeman JE, McAteer JA, Williams JC Jr: CT visible internal stone structure, but not Hounsfield unit value, of calcium oxalate monohydrate (COM) calculi predicts lithotripsy fragility in vitro. Urol Res 35: 201–206, 2007
15. Werness PG, Brown CM, Smith LH, Finlayson B: EQUIL2: A BASIC computer program for the calculation of urinary saturation. J Urol 134: 1242–1244, 1985
16. Nakagawa Y, Abram V, Parks JH, Lau HS, Kawooya JK, Coe FL: Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest 76: 1455–1462, 1985
17. Yasue T: Histochemical identification of calcium oxalate. Acta Histochem Cytochem 2: 83–95, 1969
18. Miller NL, Williams JC Jr, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Handa SE, Lingeman JE: In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall’s plaque. BJ UInt 105: 242–245, 2010
19. Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ: Calcium oxalate crystals induce renal inflammation by NLRP3- mediated IL-1b secretion. J Clin Invest 123: 236–246, 2013
20. Knauf F, Asplin JR, Granja I, Schmidt IM, Moeckel GW, David RJ, Flavell RA, Aronson PS: NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy. Kidney Int 84: 895–901, 2013
21. Al-Hayek S, Schwen ZR, Jackman SV, Averch TD: The impact of obesity on urine composition and nephrolithiasis management. J Endourol 27: 379–383, 2013
22. Chou YH, Su CM, Li CC, Liu CC, Liu ME, Wu WJ, Juan YS: Difference in urinary stone components between obese and nonobese patients. Urol Res 39: 283–287, 2011
23. Najeeb Q, Masood I, Bhaskar N, Kaur H, Singh J, Pandey R, Sodhi KS, Prasad S, Ishaq S, Mahajan R: Effect of BMI and urinary pH on urolithiasis and its composition. Saudi J Kidney Dis Transplant 24: 60–66, 2013
24. Nowfar S, Palazzi-Churas K, Chang DC, Sur RL: The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasis. Urology 78: 1029–1033, 2011